Drugs News and Research

RSS

Senate Finance Committee probing prices for hepatitis C drug

Sens. Ron Wyden, D-Ore., and Charles Grassley, R-Iowa, send letter to the drug's maker requesting information about how it set the price, which runs about $84,000 for a standard three-month regimen.

15 Jul 2014

Study examines how gardens in care homes can help patients suffering from dementia

A new study has revealed that gardens in care homes could provide promising therapeutic benefits for patients suffering from dementia.

15 Jul 2014

BAI and Novartis determine whether investigational drugs can prevent symptoms of Alzheimer's

Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.

15 Jul 2014

Hospitals, consumer groups object to Medicare rule on observation care

They say the government's effort to set rules for when someone is considered an admitted patient compromises care and still leaves many seniors with costly bills. In other Medicare news, a look at the unraveling of one scam and coverage of sex-reassignment surgery.

15 Jul 2014

A*STAR, Roche partner to identify novel drug targets for cancer treatment

A*STAR's Bioprocessing Technology Institute has entered into an agreement with one of the world's largest pharmaceutical company, Roche, to identify novel drug candidates for the detection and treatment of cancer.

15 Jul 2014

Study reveals why survival for blood cancer patients still varies between regions within Europe

Failure to get the best treatment and variations in the quality of care are the most likely reasons why survival for blood cancer patients still varies widely between regions within Europe, according to the largest population-based study of survival in European adults to date, published in The Lancet Oncology.

15 Jul 2014

Study demonstrates that Parkinson's patients are more creative than their healthy peers

Prof. Rivka Inzelberg of Tel Aviv University's Sackler Faculty of Medicine and the Sagol Neuroscience Center at Sheba Medical Center, Tel Hashomer, documented the exceptional creativity of Parkinson's patients two years ago in a review for Behavioral Neuroscience. Since then, she has conducted the first empirical study to verify a link between Parkinson's disease and artistic inclination.

15 Jul 2014

Researchers create combination drug that controls both tumor growth and metastasis

Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor's ability to grow and spread.

14 Jul 2014

CVS Caremark enters into definitive agreement to acquire Navarro Discount Pharmacy

CVS Caremark today announced that it has entered into a definitive agreement to acquire the assets of Miami-based Navarro Discount Pharmacy, the largest Hispanic-owned drugstore chain in the U.S. The transaction includes Navarro's 33 retail drugstore locations and Navarro Health Services, a specialty pharmacy serving patients with complex or chronic diseases.

14 Jul 2014

New research opens up potential new therapeutic targets for hard-to-treat food allergy

New research in Nature Genetics identifies a novel genetic and molecular pathway in the esophagus that causes eosinophillic esophagitis (EoE), opening up potential new therapeutic strategies for an enigmatic and hard-to-treat food allergy.

14 Jul 2014

Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced that the U.S. Food and Drug Administration has approved Rasuvo, a subcutaneous injectable methotrexate (MTX) therapy delivered in an auto-injector for rheumatoid arthritis (RA), polyarticular-course juvenile idiopathic arthritis (pJIA) and psoriasis.

14 Jul 2014

First Edition: July 14, 2014

Today's headlines include coverage of Medicare, the health law and veterans' care policy issues as well as reports from the campaign trail.

14 Jul 2014

Research roundup: Clinics and electronic records; young adults baffled by exchange; Medicare spending slowdown

We found that in 2012 nine out of ten health centers had adopted a EHR system, and half had adopted EHRs with basic capabilities. Seven in ten health centers reported that their providers were receiving meaningful-use incentive payments from the Centers for Medicare and Medicaid Services (CMS).

14 Jul 2014

Viewpoints: Parsing newest reports of coverage gains; 'scientific fraudsters'

It will take a while to understand fully how the Affordable Care Act affects the quality of health care and access to doctors in this country.

14 Jul 2014

Young adults reduce binge drinking after receiving text messages following visit to ER

Young adults who screened positive for a history of hazardous or binge drinking reduced their binge drinking by more than 50 percent after receiving mobile phone text messages following a visit to the emergency department, according to a study published online yesterday in Annals of Emergency Medicine ("A Text Message Alcohol Intervention for Young Adult Emergency Department Patients: A Randomized Clinical Trial").

14 Jul 2014

CRAG urges researchers to balance goal of shortening treatment for MDR-TB with patient safety

In a viewpoint published this week in The Lancet, the Community Research Advisors Group argue that research into bedaquiline – a new drug, fast tracked for multidrug-resistant tuberculosis (MDR-TB) – should proceed cautiously in people with drug-sensitive tuberculosis.

14 Jul 2014

Researchers identify new suppressor of cancer metastasis

Among patients with deadly cancers, more than 90 percent die because of metastatic spread of their disease. Looking to target a key pathway in order to interfere with the processes that lead to tumor spread, a research team led by Irwin H. Gelman, Ph.D., of Roswell Park Cancer Institute (RPCI) has identified a new suppressor of cancer metastasis that may point the way toward development of more effective treatments for prostate cancers and other malignant solid tumors.

14 Jul 2014

Drugs News and Research

Senate Finance Committee probing prices for hepatitis C drug

Study examines how gardens in care homes can help patients suffering from dementia

BAI and Novartis determine whether investigational drugs can prevent symptoms of Alzheimer's

Hospitals, consumer groups object to Medicare rule on observation care

A*STAR, Roche partner to identify novel drug targets for cancer treatment

Study reveals why survival for blood cancer patients still varies between regions within Europe

Study demonstrates that Parkinson's patients are more creative than their healthy peers

Researchers create combination drug that controls both tumor growth and metastasis

CVS Caremark enters into definitive agreement to acquire Navarro Discount Pharmacy

New research opens up potential new therapeutic targets for hard-to-treat food allergy

Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

First Edition: July 14, 2014

Research roundup: Clinics and electronic records; young adults baffled by exchange; Medicare spending slowdown

Viewpoints: Parsing newest reports of coverage gains; 'scientific fraudsters'

Young adults reduce binge drinking after receiving text messages following visit to ER

CRAG urges researchers to balance goal of shortening treatment for MDR-TB with patient safety

Researchers identify new suppressor of cancer metastasis

CYD-TDV vaccine shows moderate protection against dengue in Asian children

NeoGenomics launches 23 NGS-based NeoTYPE Cancer Profiles

Failure to provide adequate HIV services threatens global progress on HIV response, warns WHO

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News